Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Mise à jour : Il y a 4 ans
Référence : NCT01390220

Femme et Homme

Extrait

The purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.


Critère d'inclusion

  • Epilepsy


Liens